GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Earnings per Share (Diluted)

Endo (NDOI) Earnings per Share (Diluted) : $59.26 (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Earnings per Share (Diluted)?

Endo's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $59.26.

Endo's EPS (Basic) for the three months ended in Dec. 2024 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was $59.26.

Endo's EPS without NRI for the three months ended in Dec. 2024 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $-8.57.


Endo Earnings per Share (Diluted) Historical Data

The historical data trend for Endo's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Earnings per Share (Diluted) Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Earnings per Share (Diluted)
-46.33 -38.83 -

Endo Quarterly Data
Jun23 Sep23 Dec23 Apr24 Sep24 Dec24
Earnings per Share (Diluted) Get a 7-Day Free Trial -0.45 -38.70 101.02 -3.06 -

Competitive Comparison of Endo's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's PE Ratio distribution charts can be found below:

* The bar in red indicates where Endo's PE Ratio falls into.


;
;

Endo Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Endo's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0-0)/76.211
=0.00

Endo's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (Q: Dec. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0-0)/76.211
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $59.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Endo  (OTCPK:NDOI) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Endo Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Endo's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo Business Description

Industry
Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.